JAMA Medical News

The US Now Has a Research Plan for Long COVID—Is It Enough?; Debate Swirls Around the Relevance of the Amyloid Hypothesis in Alzheimer Disease Research; Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive Related Content: The US Now Has a Research Plan for Long COVID—Is It Enough? Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive Animal Reservoirs—Where the Next SARS-CoV-2 Variant Could Arise Large Autopsy Study Estimates Prevalence of "LATE" Neuropathologic Change Addressing the Long-term Effects of COVID-19 Long COVID: The US Federal Response (audio) Long COVID: The US Federal Response (video)

How Abortion Bans Could Affect Care for Miscarriage and Infertility; COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies; Code Blue—What to Do When the Shooting Starts. Related Content: COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies How Abortion Bans Could Affect Care for Miscarriage and Infertility Code Blue—What to Do When the Shooting Starts

Studies dating back to the late 1950s have shown that people with South Asian ancestry have higher cardiovascular disease risk compared with other racial and ethnic groups, and the heightened risks have been observed in the US over the past 2 decades. To better understand why, in 2010 two Indian American internists, Alka Kanaya, MD, and Namratha Kandula, MD, MPH, launched the Mediators of Atherosclerosis in South Asians Living in America, or MASALA, prospective cohort study. Drs Kanaya and Kandula spoke with JAMA Medical News Associate Managing Editor Jennifer Abbasi about cardiovascular disease and risk factors among people of South Asian descent. Related Content: MASALA Study Probes Why People With South Asian Ancestry Have Increased Cardiovascular Disease Risks

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content: The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video) A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)

The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid; What to Know About Monkeypox; UN Reports New Insights on Link Between Climate Change and Human Health. Related Content: The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid What to Know About Monkeypox UN Reports New Insights on Link Between Climate Change and Human Health

JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Sonali Smith, MD, about new research and timely topics from the recent annual meeting of the American Society of Clinical Oncology (ASCO). Dr Smith, who chaired the conference's Scientific Program Committee, is also chief of the hematology and oncology section at the University of Chicago Medicine. Related Content: Highlights From the 2022 Annual Meeting of the American Society of Clinical Oncology—Disparities in Clinical Trials, Mitigating Clinician Burnout, and Combination Treatments for Cancer Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer Cancer Risk and Mortality in Adults With Obesity Who Underwent Bariatric Surgery vs No Surgery

Loren Laine, MD, professor of Medicine (Digestive Diseases); chief, Section of Digestive Diseases, Internal Medicine; medical chief, Digestive Health, Yale New Haven Health, discusses the pandemic-related decline in colorectal cancer screening, racial and ethnic disparities in cancer care and survival, and other research highlights from the recent Digestive Disease Week meeting. Related Content: Highlights From Digestive Disease Week—Pandemic-Related Decline in Colorectal Cancer Screening, Lack of Association Between Proton Pump Inhibitors and Dementia, and More

JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Andrew J. Halayko, PhD, ATSF, MSc, BSc, about some important research studies and keynote addresses presented at the American Thoracic Society (ATS) International Conference in May 2022. Dr Halayko is professor of physiology and internal medicine at the University of Manitoba in Canada and this year's ATS conference chair. Related Article(s): American Thoracic Society 2022 Conference Highlights

What a Post–Roe v Wade US Might Look Like for Physicians; SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus Related Article(s): What a Post–Roe v Wade US Might Look Like for Physicians SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus

Clinical Trials Disrupted During War in Ukraine; The Role of Supervised Consumption Sites for People Who Use Illicit Drugs Related Content: Clinical Trials Disrupted During War in Ukraine The Role of Supervised Consumption Sites for People Who Use Illicit Drugs